Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

158
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
158
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

78
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
78
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

45.1K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
45.1K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

132
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

384
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
384
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

72
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bipartite DNA binding domain of transcription factor BCL11B binds clustered short DNA sequence motifs.

bioRxiv : the preprint server for biology·2026
Same author

A model for Crohn's disease post-ileal resection fibrosis development using human ileal enteroids and myofibroblasts.

Frontiers in physiology·2026
Same author

Structure of human lymphoid-specific helicase HELLS in its autoinhibited state.

Nucleic acids research·2026
Same author

Regulation of BCL11A DNA binding and expression in human erythrocyte precursor HUDEP-2 cells.

bioRxiv : the preprint server for biology·2026
Same author

Structure of human lymphoid-specific helicase HELLS in its autoinhibitory state.

bioRxiv : the preprint server for biology·2026
Same author

Loss of E3 ligase Ube4A Disrupts Colon Homeostasis and Accelerates Experimental Colitis via Altered Lipid Handling.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Apr 16, 2026

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters
11:51

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters

Published on: February 3, 2018

7.6K

Nonsynonymous single nucleotide polymorphisms of NHE3 differentially decrease NHE3 transporter activity.

Xinjun Cindy Zhu1, Rafiquel Sarker2, John R Horton3

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, Center of Cardiovascular Sciences, Albany Medical Center, Albany, New York; Departments of Physiology and Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.

American Journal of Physiology. Cell Physiology
|February 27, 2015
PubMed
Summary
This summary is machine-generated.

Genetic variations in the Na⁺/H⁺ exchanger 3 (NHE3) gene significantly reduce intestinal sodium absorption. Three specific single nucleotide polymorphisms (SNPs) impair NHE3 transporter function and trafficking, impacting fluid balance.

Keywords:
CHPNHE3SNPdexamethasone

More Related Videos

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

9.8K
Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays
12:48

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays

Published on: February 19, 2013

11.3K

Related Experiment Videos

Last Updated: Apr 16, 2026

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters
11:51

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters

Published on: February 3, 2018

7.6K
Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

9.8K
Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays
12:48

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays

Published on: February 19, 2013

11.3K

Area of Science:

  • Genetics
  • Molecular Biology
  • Physiology

Background:

  • Genetic factors contribute to chronic diarrhea susceptibility, but underlying genetic abnormalities are often unknown.
  • The Na⁺/H⁺ exchanger 3 (NHE3) is crucial for intestinal sodium absorption and is regulated by its C-terminal domain.
  • The impact of genetic variations, like single nucleotide polymorphisms (SNPs), on NHE3 activity is largely unexplored.

Purpose of the Study:

  • To investigate the functional consequences of three nonsynonymous SNPs in the NHE3 gene located in the C-terminal regulatory domain.
  • To determine how these identified SNPs affect NHE3 transporter activity, intrinsic function, and cellular trafficking.

Main Methods:

  • Identified three nonsynonymous SNPs (R474Q, V567M, R799C) within the NHE3 gene.
  • Expressed wild-type and variant NHE3 proteins in a mammalian cell line lacking endogenous NHEs.
  • Assessed basal transporter activity, intrinsic function, protein trafficking, and response to dexamethasone stimulation.

Main Results:

  • All three NHE3 variants (R474Q, V567M, R799C) significantly reduced basal transporter activity.
  • Variant R474Q showed reduced intrinsic function, V567M exhibited abnormal trafficking, and R799C displayed defects in both.
  • Variants R474Q and R799C failed to respond to dexamethasone, and R474Q showed aberrant interaction with the regulatory protein CHP.

Conclusions:

  • Genetic variations in NHE3, specifically the studied SNPs, decrease intestinal sodium transport activity.
  • These SNPs impact NHE3 function through reduced intrinsic activity, impaired trafficking, or both.
  • The findings provide mechanistic insights into how NHE3 genetic variations contribute to altered intestinal physiology.